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Abstract Spinal afferents such as nociceptive afferents
and group III–IV muscle afferents are known to exert an
acute excitatory effect on breathing when activated. Here,
we report the surprising existence of latent spinal afferents
which exerted tonic inhibitory influence on breathing
subliminally in anesthetized rats, an effect which was
reversed upon activation of serotonin-1A receptors (5-
HT1ARs) in lumbar spinal cord, lesion of pontine lateral
parabrachial nucleus or suppression of the adjacent Ko¨lli-
ker-Fuse nucleus with NMDA receptor blockade. Small-
interfering RNA knockdown of 5-HT1ARs in lumbar spinal
cord unequivocally localized the site of 5-HT1AR-mediated
gating of these respiratory-inhibiting interoceptive affer-
ents to relay neurons in the spinal superficial dorsal horn at
the lumbar level and not cervical spinal or supraspinal
levels. Our results reveal a novel somatosensory/vis-
cerosensory mechanism which exerts tonic inhibitory
influence on homeostatic regulation of breathing indepen-
dent from the classical chemoreflex excitatory pathways,
and suggest a hitherto unrecognized therapeutic target in
spinal dorsal horn for 5-HT1AR-based treatment of a vari-
ety of respiratory abnormalities.
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Introduction
Serotonin or 5-hydroxytryptamine (5-HT) is a ubiquitous
monoamine neurotransmitter which plays an important role
in many physiological and behavioral functions. Among
the family of 5-HT receptors, the 1A receptor subtype (5-
HT1AR) is most pervasive in the central nervous system
(Fiorino et al. 2014) and has been widely considered as a
therapeutic target for various brain disorders including
anxiety and depression, schizophrenia, Parkinson’s disease
and cognitive dysfunction (Lacivita et al. 2012; Celada
et al. 2013). There is increasing evidence that 5-HT1AR
activation may be beneficial in reversing a variety of res-
piratory abnormalities such as irregular apneas in sudden
infant death syndrome (Audero et al. 2008; Duncan et al.
2010) and Rett syndrome (Abdala et al. 2010), apneustic
disturbances following brain injuries (Lalley et al. 1994;
Wilken et al. 1997; El-Khatib et al. 2003), and respiratory
depression caused by spinal cord injury (Teng et al. 2003;
Choi et al. 2005) or opioids (Sahibzada et al. 2000; Zhuang
et al. 2012).
In contrast to 5-HT1AR’s well-known actions in brain
circuits, 5-HT1ARs are also heavily localized in the
superficial laminae (I and II) of spinal cord dorsal horn
especially at the lumbar and sacral levels (Marlier et al.
1991; Thor et al. 1993; Manzke et al. 2009). Neurons in
these dorsal horn regions receive monosynaptic inputs
from small-diameter (Ad and C) primary afferent fibers
which convey diverse sensory information from the
periphery such as pain, temperature, itch, sensual touch,
as well as muscular and visceral sensations and vasomotor
activity (Craig 2002, 2003, 2015; Todd 2010; Jankowski
et al. 2013). Transmission of these interoceptive afferent
signals is gated by serotonergic inhibition of spinal
superficial dorsal horn neurons through the activation of
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pre- and/or postsynaptic 5-HT1ARs (Yoshimura and Furue
2006; Lu and Perl 2007; Jeong et al. 2012). Lamina I
neurons receiving these interoceptive inputs send
ascending projections to the thalamus en route to the
somatosensory cortex to modulate affective arousal (Craig
et al. 1994; Craig 2002, 2015). These spinothalamic
projections also have extensive collaterals that terminate
predominantly in the lateral parabrachial nucleus (LPBN)
(Cechetto et al. 1985; Hylden et al. 1989; Feil and Herbert
1995; Gauriau and Bernard 2002; Nakamura and Mor-
rison 2008; Kayalioglu 2009; Nakamura and Morrison
2010) and adjacent Ko¨lliker-Fuse nucleus (KFN) in the
parabrachial complex in dorsolateral pons (Cechetto et al.
1985; Feil and Herbert 1995), both of which are known to
play an important role in modulating breathing (Song
et al. 2006, 2015; Song and Poon 2009a, b; Dutschmann
and Dick 2012). Neurons in the LPBN have been shown
to mediate the excitatory effect of cutaneous nociception
on inspiratory motor activity in anesthetized rats (Jiang
et al. 2004).
Because somatosensory/viscerosensory receptors are
generally presumed to be quiescent until provoked, the
functional significance of 5-HT1AR-dependent gating of
interoceptive inputs in spinal dorsal horn has been lar-
gely ignored in the literature except as a possible
pharmacological target for the development of new
therapies for pain relief (Colpaert 2006). Most previous
studies have ascribed the complex excitatory-inhibitory
effects of systemic 5-HT1AR agonists on breathing
exclusively to their actions in brainstem respiratory-re-
lated networks (Lalley et al. 1994; Wilken et al. 1997;
Sahibzada et al. 2000; El-Khatib et al. 2003; Teng et al.
2003; Choi et al. 2005; Abdala et al. 2010; Zhuang
et al. 2012; Corcoran et al. 2014). However, conflicting
evidences reported in the literature have led to the
hypothesis that the excitatory effect of 5-HT1AR acti-
vation on breathing may be attributed in part to disfa-
cilitation of a latent 5-HT1AR-gated spinal afferent
pathway which normally exerts a paradoxical tonic
inhibitory effect on breathing even in the quiescent
state without explicit sensory provocations (Poon 2009).
Here, we employed small-interfering RNA (siRNA)
technology to unequivocally verify the respiratory-in-
hibiting effect of a hitherto unrecognized 5-HT1AR-
gated spinal afferent pathway and to localize the site of
action to 5-HT1ARs in lumbar spinal cord dorsal horn.
Our results uncovered a latent somatosensory/vis-
cerosensory mechanism which exerted tonic inhibitory
influence on homeostatic regulation of breathing sub-
liminally in the quiescent state independent from the
classical chemoreflex excitatory pathways (Mulkey
et al. 2004; Kumar and Prabhakar 2012).
Results
Tonic respiratory inhibition by latent 5-HT1AR-
gated spinal afferents
First, we tested whether respiration was influenced by
5-HT1AR modulation of spinal afferents that were persistently
active in the quiescent state unprovoked (i.e., without any
acute somatosensory or viscerosensory stimuli being applied)
in anesthetized rats. To minimize possible interference of
phrenic motor neurons directly or indirectly through local
spinal 5-HT1AR-dependent reflex in cervical spinal cord
(Zimmer and Goshgarian 2006), we kept all spinal adminis-
trations of 5-HT1AR agonist and antagonist at the lumbar level
where 5-HT1AR expression is reportedly the highest espe-
cially in the dorsal horn and rarely in the ventral horn (Marlier
et al. 1991; Thor et al. 1993). Post-experimental Sky Blue
injection (2 %, 20 ll at the same location of drug injection
with 20 min diffusion time) showed that the Sky Blue staining
of spinal cord was mainly within the lumbar level and no
staining could be visually observed beyond lumbar level.
Intrathecal injection of the 5-HT1AR agonist 8-OH-
DPAT [(R)-(?)-8-Hydroxy-DPAT, 0.5 lg/ll, 20 ll] into
the rat spinal cord subarachnoid space at lumbar level
caused pronounced respiratory augmentation (Fig. 1a). At
*3 min after injection, inspiratory amplitude (as measured
by integrated phrenic activity,
R
phr) was increased by
57.8 ± 7.9 % (mean ± SE; p\ 0.001 two-tailed paired
t test, n = 11) and respiratory frequency by 26.6 ± 10.1 %
(p\ 0.05), whereas inspiratory and expiratory durations
were decreased by 14.1 ± 7.1 % (p\ 0.05) and
19.2 ± 3.6 % (both p\ 0.001), respectively (Fig. 1b). As
a result, inspiratory drive (inspiratory amplitude/inspiratory
duration) and neural ventilatory output (inspiratory ampli-
tude 9 respiratory frequency) increased markedly by
102.0 ± 14.1 and 103.0 ± 23.0 %, respectively (Fig. 1c).
These respiratory augmentation effects remained stable for
[30 min after lumbar-intrathecal 8-OH-DPAT injection
while the animal remained anesthetized and unprovoked.
Conversely, lumbar-intrathecal injection of the 5-HT1AR
antagonist WAY-100635 (2 lg/ll, 20 ll) caused respira-
tory depression (Fig. 1b). At *8 min after injection,
inspiratory amplitude was reduced by 21.2 ± 2.5 % and
inspiratory duration lengthened by 10.4 ± 2.9 % (both
p\ 0.001, n = 7) although changes in expiratory duration
and respiratory frequency were not statistically significant
(both p[ 0.1, Fig. 1b). Consequently, inspiratory drive
and neural ventilatory output showed significant decreases
by 27.3 ± 2.9 and 24.8 ± 4.2 %, respectively (both
p\ 0.001, Fig. 1c). The effects of lumbar-intrathecal
8-OH-DPAT and WAY-100635 were without explicit
provocation of any somatosensory/viscerosensory stimuli.
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As shown in Table 1, intravenous administration of
8-OH-DPAT also elicited an augmentation of inspiratory
amplitude (by 45.5 ± 6.0 %) and shortening of inspiratory
duration (by -14.8 ± 2.3 %). However, these effects were
accompanied by a prolongation of expiratory duration (by
14.5 ± 4.8 %) unlike lumbar-intrathecal 8-OH-DPAT,
which induced a shortening of expiratory duration
(Fig. 1b). The effects of intravenous 8-OH-DPAT on res-
piration were attenuated or abolished by subsequent WAY-
100635 administration (5-min post-intravenous agonist
injection), either intravenously or intrathecally at the
lumbar level (Table 1). Thus, the respiratory effects of
intravenous 8-OH-DPAT were ascribable largely (but not
totally) to activation of spinal 5-HT1ARs.
Lateral parabrachial nucleus mediation of spinal
5-HT1AR disinhibition of respiration
Next, we sought to identify the brainstem sites potentially
mediating the observed lumbar-spinal 5-HT1AR
Fig. 1 A 5-HT1AR-gated spinal-LPBN pathway mediating
somatosensory/viscerosensory modulation of respiration in anes-
thetized rats without sensory provocations. a Phrenic motor activity
at constant end-tidal PCO2 (ECO2) before and after intrathecal
administration of the 5-HT1AR agonist 8-OH-DPAT at lumbar level
in control rat (upper) and LPBN kainic acid-lesioned rat (lower). b
Normalized group data showing the effects of lumbar-intrathecal
administrations of 8-OH-DPAT and the 5-HT1AR antagonist WAY-
100635 on respiratory pattern before and after LPBN lesion. Amp
amplitude of
R
phr, f respiratory frequency, TE expiratory duration, TI
inspiratory duration. c Corresponding effects on inspiratory drive
(Amp/TI) and neural ventilatory output (Amp 9 f). d Histological
section showing the center (red arrow) of kainic acid microinjection
in LPBN in one representative animal. Red asterisks indicate artifacts
(which are of no consequence to the study). KF Ko¨lliker-Fuse
nucleus, LPBN lateral parabrachial nucleus, SCP superior cerebellar
peduncle
Table 1 Effects of systemic 5-HT1AR agonist followed by systemic or intrathecal antagonist on respiration
8-OH-DPAT i.v. (n = 8) (%) WAY-100635 i.v. (n = 3) (%) WAY-100635 intrathecal (n = 5) (%)
Norm.
R
phr 45.5 ± 6.0* -5 ± 11 9.2 ± 3.5*
Norm. TI -14.8 ± 2.3* -7.5 ± 8.3 -7.9 ± 6.9
Norm. TE 14.5 ± 4.8* 10.9 ± 4.0 10.0 ± 7.5
Antagonists were applied at 5 min post-intravenous agonist injection. All values are percentage changes over pre-injection baseline levels
* p\ 0.05 vs. pre-injection baseline
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disinhibition of respiration. In animals subjected to unilateral
lesion of LPBN with kainic acid microinjection (Fig. 1d), no
significant changes in respiratory parameters were observed
30 min after lesion (Table 2), as previously reported (Song
and Poon 2009a). However, LPBN lesion reversed the
expiratory duration and respiratory frequency responses to
lumbar-intrathecal injection of 8-OH-DPAT (Fig. 1a, b),
increasing (instead of decreasing) expiratory duration by
15.9 ± 4.0 % and decreasing (instead of increasing) respi-
ratory frequency by 9.0 ± 2.6 % at peak (p\ 0.01 and
p\ 0.05, respectively, n = 8). After LPBN lesion, lumbar-
intrathecal 8-OH-DPAT injection caused much smaller (al-
beit significant) increase in inspiratory amplitude
(22.7 ± 9.3 %, p\ 0.05) while the shortening of inspira-
tory duration was all but abolished (p[ 0.1). Similarly, the
effects of WAY-100635 on inspiratory amplitude and
inspiratory duration were significantly reduced after LPBN
lesion (both p\ 0.05, n = 7; Fig. 1b). Consequently, the
responses in inspiratory drive and neural ventilatory output
to 8-OH-DPAT and WAY-100635 were markedly sup-
pressed after unilateral LPBN lesion (all p\ 0.001; Fig. 1c),
indicating that integrity of the LPBN was required in medi-
ating the effects of intrathecal 8-OH-DPAT and WAY-
100635 on respiration.
siRNA knockdown of lumbar-spinal dorsal horn
5-HT1ARs
Pharmacological modulation of spinal 5-HT1AR activity
suffers from potential confounds such as limited selectivity
and durability of the injected agonist and antagonist as well
as their possible diffusion from the lumbar spinal cord to
respiratory-related circuits in the cervical spinal cord or
supraspinal structures. To circumvent these potential
drawbacks, small-interfering RNA (siRNA; InvitrogenTM)
with high target specificity for 5HT1AR and minimum
in vivo immune response or its scrambled negative control
was injected to rat spinal cord between L4 and L5 under
pentobarbital anesthesia. Previous studies have shown that
in vivo siRNA knock-down of receptor or protein expres-
sions typically peaks at 7–14 days post-injection, and dis-
appears after 21 days post-injection (Song et al. 2003; Tan
et al. 2005). Accordingly, in this study all tests were per-
formed on the 14th day post-injection.
Fourteen days post-injection, baseline respiration in
5-HT1AR knockdown rats was depressed (i.e., more inhib-
ited) compared with negative controls mainly due to a sig-
nificant decrease in respiratory frequency secondary to a
prolongation of expiratory duration (both p\ 0.05, Fig. 2a).
As in normal animals, scrambled negative control rats
showed pronounced increases in inspiratory amplitude and
respiratory frequency with significant shortening of expira-
tory and inspiratory durations in response to lumbar-in-
trathecal 8-OH-DPAT injection (all p\ 0.01 at *8 min,
n = 8; Fig. 2b). Corresponding responses were greatly
attenuated or abolished in 5-HT1AR knockdown rats com-
pared with negative controls (Fig. 2b, p\ 0.01, n = 8).
Immunohistological examination post-experiment
revealed that the level of 5-HT1AR expression in lumbar
spinal cord was markedly reduced (by[60 %) in 5-HT1AR
knockdown rats (n = 8) compared with negative controls
(n = 8)—the latter showing the highest density of
5-HT1AR immunopositive staining in the superficial layers
(laminae I and II) of dorsal horn and much lower in the
ventral horn (Fig. 2c). 5-HT1AR expression at the cervical
level was not affected by lumbar siRNA injection (Fig. 2c).
These data confirm that the respiratory disinhibition effects
of lumbar-intrathecal 8-OH-DPAT injection were mediated
by activation of 5-HT1ARs localized primarily in the
superficial layers of lumbar-spinal dorsal horn independent
of cervical spinal and supraspinal 5-HT1ARs.
Distinct spinal/supraspinal 5-HT1AR modulation
of respiration
Previous studies have shown that systemic 5-HT1AR ago-
nists can reverse the apneustic disturbances (i.e., pronounced
prolongation of inspiratory duration) resulting from a variety
of respiratory defects in patients and animal models (Wilken
et al. 1997), presumably via 5-HT1AR-mediated enhance-
ment of glycinergic inhibition in brainstem respiratory net-
works (Manzke et al. 2009, 2010). Consistent with this view,
we found that microinjection of the specific NMDA (N-
Methyl-D-aspartate) receptor antagonist AP5 (20 mM) into
the KFN unilaterally induced an apneustic pattern (Fig. 3a;
Table 2) (Song et al. 2015) that was completely reversed by
intravenous administration of 8-OH-DPAT (20 lg/kg)
Table 2 Baseline respiratory patterns before and after pontine
microinjections
Before After
LPBN KA (n = 9)
Amp 5.42 ± 0.44 6.01 ± 0.56
f (min-1) 40.2 ± 2.2 45.2 ± 4.2
TE (s) 1.03 ± 0.08 0.88 ± 0.1
TI (s) 0.52 ± 0.03 0.52 ± 0.07
KFN AP5 (n = 6)
Amp 8.6 ± 0.3 6.5 ± 0.5*
f (min-1) 36.4 ± 2.6 28.7 ± 3.0*
TE (s) 1.13 ± 0.11 1.08 ± 0.1
TI (s) 0.60 ± 0.06 0.85 ± 0.07*
Data are mean ± SE of 1-min recordings
KA kainic acid
* p\ 0.05 (two-tailed paired t test)
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(n = 3, p\ 0.05; Fig. 3a, c). In contrast, lumbar-intrathecal
injection of 8-OH-DPAT had no effect on the apneustic
pattern (p[ 0.1, Fig. 3b). These data confirm that the anti-
apneustic effect of 8-OH-DPAT was mediated predomi-
nantly by activation of 5-HT1ARs in supraspinal respiratory
networks rather than spinal dorsal horn.
Ko¨lliker-Fuse nucleus mediation of spinal 5-HT1AR
disinhibition of respiration
After microinjection of AP5 into KFN, 8-OH-DPAT
whether administered intrathecally or intravenously no
longer elicited a disinhibition of respiration (Fig. 3b, c).
These data indicate that the KFN also contributed impor-
tantly to the lumbar-spinal 5-HT1AR modulation of respi-
ration independently from the LPBN.
Discussion
The present results provide the first direct experimental
evidence revealing a latent (i.e., persistently active in the
quiescent state without explicit sensory provocation)
5-HT1AR-gated spinal afferent pathway (or collection of
pathways) which exerts profound tonic inhibitory influence
on respiration, as conjectured previously (Poon 2009). Our
results with lumbar-intrathecal 8-OH-DPAT injection after
siRNA knockdown of 5-HT1AR unequivocally localized
the site of action of 8-OH-DPAT to (pre- and/or postsy-
naptic) 5-HT1ARs in the superficial layers of spinal dorsal
horn at the lumbar level and not cervical level or higher.
Hence, potential confounds associated with the activation
of presynaptic or postsynaptic 5-HT1ARs in cervical spinal
cord or brainstem respiratory-related circuits were elimi-
nated, although possible contribution of other receptor
subtypes cannot be excluded. Because only a very low
dosage of 8-OH-DPAT or WAY-100635 was injected
intrathecally at the lumbar level, any resultant changes in
blood pressure and their effects on breathing should be
minimal. This latent 5-HT1AR-gated respiratory-inhibiting
spinal afferent pathway signifies a novel somatosensory/
viscerosensory mechanism which contributes importantly
to the homeostatic regulation of breathing in the quiescent
state independent of the classical chemoreflex excitatory
pathways (Mulkey et al. 2004; Kumar and Prabhakar
2012).
Fig. 2 Effects of siRNA
knockdown of 5-HT1ARs in
lumbar spinal cord on
respiration. a Baseline
respiratory patterns of 5-HT1AR
knockdown rats vs. scrambled
negative controls. b Normalized
group data showing the
respiratory responses to lumbar-
intrathecal 8-OH-DPAT
injection in 5-HT1AR
knockdown rats vs. scrambled
negative controls. (Note that in
the top panel (Norm.
R
phr) the
error bars for the siRNA group
are too small to be visible). c 5-
HT1AR expression in lumbar
and cervical spinal cord of
5-HT1AR knockdown rat vs.
scrambled negative control
14 days post-siRNA injection at
the lumbar spinal cord. Red
arrows indicate 5-HT1AR
expression in superficial layers
of dorsal horns. Bar graphs at
bottom show relative intensity
of 5-HT1AR expression (in
pixels/sq. in) in the dorsal horn
of lumbar vs. cervical spinal
cords of 5-HT1AR knockdown
rats vs. scrambled negative
controls
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Suppression of lumbar-spinal 5-HT1ARs with chronic
siRNA knockdown or acute antagonism with WAY-
100635 both resulted in respiratory depression. However,
the respiratory depression in 5-HT1AR knockdown rats was
manifested as a decrease in respiratory frequency sec-
ondary to a prolongation of expiratory duration instead of a
decrease in inspiratory amplitude and prolongation of
inspiratory duration that were seen after lumbar-intrathecal
WAY-100635 injection in normal rats. Possible causes for
such subtle discrepancy include the limited specificity of
WAY-100635 and limited potency of siRNA, or that the
siRNA-treated rats adapted their respiratory pattern in
compensation for the effects of the 5-HT1AR knockdown
over the 14 days incubation period.
It is presently unclear which specific somatosensory/
viscerosensory modalities underlie this latent inhibitory
effect on respiration. Certain modalities such as pain
afferents (Jiang et al. 2004) and small-fiber (group III–
IV) muscle mechanosensitive or metabosensitive affer-
ents (Poon and Song 2015) may be ruled out in this
regard because of their known excitatory (instead of
inhibitory) effects on breathing. Similarly, large-fiber
(group I and II) proprioceptive afferents from limb
muscles and joints [mainly via the spinal dorsal column
(Kayalioglu 2009; Craig 2015) instead of dorsal horn]
may also be ruled out because of their reported exci-
tatory entrainment effects on breathing (Potts et al.
2005; Giraudin et al. 2012). A spinoparabrachial ther-
moregulatory pathway has been previously proposed as
a possible candidate that potentially contributes to a
spinal 5-HT1AR-gated respiratory inhibition (Poon
2009). However, although cutaneous warm and cold
stimuli have been shown to elicit a powerful defensive
autonomic response via this spinoparabrachial pathway
(Nakamura and Morrison 2008, 2010), there is currently
no evidence that these cutaneous thermosensory inputs
exert a tonic inhibitory effect on breathing particularly
in the quiescent state unprovoked. Indeed, cutaneous
temperature sensors such as the family of transient
receptor potential (TRP) channels are known to also
serve as nociceptors (Clapham 2003), the activation of
which has been shown to stimulate instead of inhibit
breathing (Jiang et al. 2004). Similar considerations
may also be applicable to spinoparabrachial mediation
of bone nociception (Williams and Ivanusic 2008).
Besides these somatosensory modalities, little is cur-
rently known about a diverse array of spinal afferents
mediating viscerosensory information and their effects
on control of breathing (Bernard et al. 1994; Cervero
and Laird 1999). Further studies are needed to pinpoint
the specific somatosensory/viscerosensory mechanisms
underlying the latent spinal 5-HT1AR-gated respiratory-
inhibiting effect revealed by the present study.
In the rat, neurons in the superficial dorsal horn of
lumbar spinal segments project primarily to the dorsal
subdivision of LPBN and to a lesser extent the central
subdivision (Feil and Herbert 1995). Although the loci of
our kainic acid microinjections were localized mainly to
Fig. 3 A 5-HT1AR-gated spinal-KFN pathway mediating somatosen-
sory/viscerosensory modulation of respiration in anesthetized rats
without sensory provocations. a Top panel: examples of phrenic
motor activity in control rat and after KFN AP5 injection, lumbar-
intrathecal injection and intravenous injection 8-OH-DPAT. Bottom
panel: red arrowhead indicates the center of AP5 microinjection in
KFN. b Normalized group data showing the effects of lumbar-
intrathecal 8-OH-DPAT injection on respiratory pattern after KFN
AP5 microinjection. c Corresponding effects of intravenous 8-OH-
DPAT injection
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the central subdivision of LPBN (as verified by post-ex-
perimental histological examination Fig. 1d), the dosage
of injection (50 nl at a concentration of 1 lg/ll) was such
that a major part of the LPBN (including its dorsal sub-
division) located within 0.5–1.0 mm around the center of
injection would have been destroyed (Mizusawa et al.
1995; Song and Poon 2009a, b). Hence, the respiratory
effects of LPBN lesion elicited by lumbar-intrathecal
injection of 8-OH-DPAT or WAY-100635 are ascribable
to the interruption of a 5-HT1AR-gated lumbar spinopar-
abrachial pathway, as previously conjectured (Poon
2009). Interestingly, blockade of NMDA receptors at
KFN was similarly effective as LPBN lesion in reversing
the respiratory-disinhibiting effect of 8-OH-DPAT. In the
rat, KFN does not receive projections from lumbar
superficial dorsal horn neurons but instead receives pro-
jections from those at the cervical levels (Feil and Herbert
1995). However, KFN receives projections from LPBN
(Yoshida et al. 1997) that are targets of the 5-HT1AR-
gated lumbar spinoparabrachial pathway mediating the
latent respiratory-inhibiting afferents. Blockade of
NMDA receptors at KFN may therefore indirectly disrupt
the respiratory-inhibiting effect of the lumbar spinopar-
abrachial pathway by suppressing certain NMDA recep-
tor-dependent neurons [such as post-inspiratory driver
neurons (Song et al. 2015)] in KFN that are the down-
stream relaying neurons of LPBN.
LPBN neurons may be either excited or inhibited by
somatosensory/viscerosensory stimuli (Bernard et al.
1994). Future studies should verify whether this 5-HT1AR-
gated lumbar spinoparabrachial respiratory-inhibiting
pathway is glutamatergic (impinging on a respiratory-in-
hibiting network in LPBN-KFN) or GABAergic/glyciner-
gic (impinging on a respiratory-exciting network). In
addition, somatic afferents (e.g., those from skeletal mus-
cles) may also be relayed by spinal lamina I neurons
directly to the medullary respiratory circuits (Wilson et al.
2002). Whether this pathway is also subject to 5-HT1AR-
gating remains to be studied.
Our results support the notion that the anti-apneustic
effect of systemic 5-HT1AR activation is mediated by the
action of 5-HT1AR in supraspinal rather than spinal respi-
ratory networks. In the present study, apneusis-like
breathing was induced in vagotomized rats by NMDA
receptor blockade at KFN, a procedure which has been
shown to suppress post-inspiratory neural activity and
abolish the post-inspiratory phase of the respiratory rhythm
(Song et al. 2015). Our results suggest that activation of
supraspinal 5-HT1ARs reversed the apneusis and restored
normal inspiratory–expiratory phase transition by activat-
ing brainstem respiratory-related circuits that are inde-
pendent from post-inspiratory activity and
spinoparabrachial afferent activity.
In conclusion, we have identified a latent 5-HT1AR-
gated spinal afferent pathway (or collection of afferent
pathways) which exerted powerful tonic inhibition on
respiration subliminally without any explicit sensory
provocations. Activation of 5-HT1ARs in spinal dorsal horn
at the lumbar level or suppression of the neural circuits in
LPBN or KFN in dorsolateral pons shut down this latent
pathway thereby eliciting pronounced respiratory disinhi-
bition. The remarkable potency of this latent 5-HT1AR-
gated spinoparabrachial afferent pathway suggests that
homeostatic regulation of breathing may be continually
modulated subliminally by certain tonic somatosensory
and/or viscerosensory respiratory-inhibiting inputs inde-
pendent from the classical chemoreflex excitatory path-
ways. Further studies are needed to investigate whether
these latent somatosensory/viscerosensory respiratory-in-
hibiting inputs are also active in the unanesthetized state
and exert tonic modulation of affective arousal via the
spinothalamic pathway in behaving animals. These find-
ings are of potential translational significance in light of the
increasing proposed use of 5-HT1AR-based therapeutics for
a wide range of neurological and respiratory disorders and
chronic pain.
Materials and methods
Animal preparation
Experiments were performed on 35 Sprague–Dawley
male rats (330–380 g Charles River Laboratories, Wilm-
ington, MA). Experimental protocols were as reviewed
and approved by the M.I.T. Committee on Animal Care in
accordance with published guidelines. Rats were anes-
thetized with urethane at an initial dose of 1.5 g/kg (i.p.).
Supplemental dose (1/10 of the initial dose) was given
when a noxious stimulus (clamp at hind paw) caused
withdrawal response, changes in respiratory rhythm and
heart rate. Other animal procedures were as previously
described (Song and Poon 2009a). Rats were paralyzed
with pancuronium bromide (Hospira Inc. Lake Forest, IL;
initial dose 0.5 mg, i.v., supplemented every hour at
0.1 mg, i.v.) and ventilated with hyperoxic medical air
(O2 enriched to 40 %) by using a CWE AVS-1 ventilator
(CWE, Ardmore, PA). A respiratory gas analyzer (CWE
Gemini) was used to monitor end-tidal O2 and CO2 levels.
Throughout the experiment the end-tidal CO2 level was
maintained at 5.0 ± 0.2 % (38 ± 1.5 mmHg), which was
the CO2-recruitment threshold (Boden et al. 1998) plus
1.0 %. Body temperature was kept at 36.5 ± 0.2 C with
a temperature controller (CWE, TC-831). During the
experiment, the depth of anesthesia was checked every
15 min. Whenever a noxious stimulus (clamping the hind
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paw) caused changes in pupil size, respiration and heart
rate or elicited a withdrawal reflex, a supplementary dose
of urethane (1/10 original dosage) was given intra-
venously to maintain adequate anesthesia. The right
phrenic nerve and both vagus nerves were isolated and
severed at the cervical level from ventral approach. The
head of the rat was then fixed in a stereotaxic frame
(KOPF 1430, David Kopf Instruments, Tujunga, CA) in a
tilted position (with Bregma 1.5 mm higher than Lambda)
with the dorsolateral pons being readily accessible from a
vertical dorsal approach.
Electrophysiological recording
To record phrenic discharge, the isolated right phrenic
nerve was exposed from dorsal approach and mounted on a
parallel bipolar platinum wire electrode. The raw phrenic
discharge signal (Phr) was amplified (CyberAmp 380,
Axon Instruments, Union City) and sampled (at 10 kHz)
into a Dell PC with LabView (National Instruments, Aus-
tin, TX). In most experiments, the phrenic discharge was
integrated with an analog Paynter filter (time constant
15 ms).
Intrathecal injection
Procedures for intrathecal injection were as described in
(Yaksh and Rudy 1976). Briefly, the atlanto-occipital
membrane was exposed by retracting the superficial neck
muscles and removing overlying soft tissue. Then a small
puncture was made in the membrane. A thin sterilized
polyethylene tube (PE-10) filled with ACSF was inserted
into the spinal subarachnoid space through this small
puncture and advanced caudally. Once the tube was
inserted to a pre-determined depth (lumbar spinal cord at
vertebral level T9, 60 mm from atlanto-occipital foramen),
the neck muscles and skin were sutured. At the end of the
experiment, the animal’s spinal cord was exposed to check
the actual location of tube. If the spinal cord was damaged
by the tube, or the tube was misplaced to a wrong spinal
segment, related data were abandoned. Injections of 8-OH-
DPAT or WAY-100635 (Sigma-Aldrich, St. Louis, MO;
dissolved in ACSF at 0.5 and 2 lg/ll, respectively) were
performed using a Hamilton microsyringe at a speed of 1
ll/3 s. The total volume of injection for each drug was
20 ll. ACSF was used for control injection. To verify the
extent of diffusion of the injection, at the end of the
experiment 20 ll of a Sky Blue solution (2 %, dissolved in
ACSF) was injected to the same spinal cord segment.
20 min after injection of the Sky Blue solution, the animal
was euthanized with urethane overdose (2 g/kg, i.v.) and
the spinal cord immediately removed to examine the Sky
Blue staining of spinal cord.
Pontine microinjection
Chemical lesion of the LPBN was made unilaterally using
a glass micropipette (tip diameter 15–30 lm) filled with
kainic acid solution (Sigma-Aldrich; 1 lg/ll in ACSF).
Stereotaxic coordinates of the LPBN were -0.12 mm
(caudal) to 0.24 mm (rostral) from interaural level,
2.3–2.6 mm lateral from midline, and 7–7.5 mm below
lambda surface (Paxinos and Watson 2007). Microinjection
was made at loci where electrical stimulation caused
increase of respiratory frequency and inspiratory amplitude
(Lara et al. 1994). A total volume of 50 nl was injected by
applying multiple pressure pulses to the micropipette using
a BH2 microinjector (Harvard Apparatus, Holliston, MA).
AP5 (Sigma-Aldrich; 20 mM in ACSF) was injected
bilaterally into KFN with the same method as described
above for kainic acid microinjection. The stereotaxic
coordinates of the KFN were 2.4–2.8 mm lateral from
midline, -0.12 mm (caudal) to 0.36 mm (rostral) from
interaural level, vertical depth at 7.4–8 mm from lambda
surface (Paxinos and Watson 2007). Injection was made at
loci where electrical stimulation caused inspiratory inhi-
bition (Song et al. 2015, BSF).
For all microinjections, a small lesion was made at the
injection site at the end of the experiment by passing
anodal D.C. current (100 lA for 60 s) through the injection
pipette. The rat was then euthanized with urethane over-
dose (2 g/kg, i.v.) and perfused with 4 % paraformalde-
hyde. The brainstem was removed and cut into 100-lm
sections for histological examination of the injection loci
(Fig. 1). Animals with inadvertent misplaced microinjec-
tions (outside of LPBN or KFN) were excluded from
analysis.
siRNA knockdown of spinal 5-HT1ARs
and immunohistochemistry
5-HT1AR Stealth
TM in vivo siRNA 50-ACGUGACCUU-
CAGCUACCAAGUGAU and its scrambled negative
control (Medium GC Duplex, Cat. No. 12935-300, Invit-
rogenTM) were dissolved in 5 % glucose solution with
RNase-free water at a concentration of 1 lg/ll as stock
solution. One microgram of siRNA was mixed with 0.18 ll
of polyethyleneimine (PEI, Fermentas). Totally 5 lg
siRNA in 20 ll was intrathecally delivered by bolus
injection after a puncture was made by a 27G needle
between vertebral levels T9 and T10 (corresponding to
spinal cord L4 and L5 segments) under pentobarbital
anesthesia. Because siRNA effect typically peaks at 7th to
14th day post-injection (Song et al. 2003; Tan et al. 2005),
rats were studied 14 days post-injection under urethane
anesthesia as described above for normal rats (not injected
with siRNA or scrambled control).
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Immunomicroscopy
After the siRNA knockdown experiment, rats were eutha-
nized with urethane overdose (2 g/kg, i.v.) and transcar-
dially perfused with PBS followed by 4 %
paraformaldehyde (dissolved in PBS). 1 cm of cervical
spinal cord was taken out and post-fixed in 4 %
paraformaldehyde. 40-lm frozen sections were cut with
frozen microtome and the sections were incubated in pri-
mary rabbit anti-5-HT1A antibody (EMD Millipore Cat#
AB15350 RRID:AB_805421) at 1:500 dilution for 48 h at
4 C, rinsed, incubated in biotinated secondary antibody
and visualized with standard ABC-DAB method. All spinal
sections were processed together under identical condi-
tions. Quantitative analysis of immunohistochemistry
positive staining intensity was done with National Insti-
tutes of Health ImageJ image processing and analysis
software.
Data analyses
The amplitude of integrated phrenic discharge (
R
phr),
inspiratory and expiratory durations (TI, TE) and respiratory
frequency (f) were measured for each respiratory cycle. All
measured values were normalized against corresponding
pre-test baseline values in control or post-injection condi-
tions, and averaged every 10 s and expressed as
mean ± SE. Student t test and ANOVA (one-way or two-
way ANOVA with repeated measures followed by Tukey
post hoc analysis) were used to determine statistical sig-
nificance. A confidence level of 95 % was used.
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